FY2025 SEC EDGAR DEF 14A #31 of 168 in industry

Bristol Myers Squibb Co CEO pay ratio

The CEO earned $21.9M in FY2025 against median worker pay of $167,191 · Chemicals & Pharmaceuticals.

State
DE
Filing date
2026-03-25
Industry
Chemicals & Pharmaceuticals
Industry rank
#31/168

Data updated August 2026

Subscribe to Bristol Myers Squibb Co CEO pay filing updates (RSS)

CEO-to-worker pay ratio
131:1
Moderate (Scale: 0–1000:1)
CEO pay
$21.9M
Median worker
$167,191

Answer first

Bristol Myers Squibb Co's FY2025 CEO total of $21.9M ranks #146 of 1,423 complete filings; its 131:1 pay ratio ranks #494. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $167,191. Industry placement uses the FY2025 SIC-28 peer cohort (# 31 of 168, 82nd percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#146
$21.9M of 1,423 FY2025
Ratio rank
#494
131:1 of 1,423
Industry pct
82nd
top quartile of industry peers by pay ratio

How Bristol Myers Squibb Co ranks nationally

Bristol Myers Squibb Co CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$21,902,021 Top 10% higher than 90% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). This entry sits in this band. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Bristol Myers Squibb Co vs. Chemicals & Pharmaceuticals peers

CEO total pay ($21.9M) against pay ratio (131:1) for Bristol Myers Squibb Co (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both7194516.711046482.114898447.518750412.922602378.437.3:163.4:189.5:1115.6:1141.8:1CEO total payPay ratio (CEO : median worker)Bristol Myers Squibb Co, CEO total pay: 21902021 · Pay ratio (CEO : median worker): 131:1Bristol Myers Squibb CoAxalta Coating Systems Ltd., CEO total pay: 9551721 · Pay ratio (CEO : median worker): 130:1Axalta Coating Systems Ltd.Amphastar Pharmaceuticals, Inc., CEO total pay: 8309350 · Pay ratio (CEO : median worker): 135:1Amphastar Pharmaceuticals, Inc.Ingevity Corp, CEO total pay: 13134086 · Pay ratio (CEO : median worker): 127:1Ingevity CorpBalchem Corp, CEO total pay: 7894874 · Pay ratio (CEO : median worker): 135:1Balchem CorpFuller H B Co, CEO total pay: 8830569 · Pay ratio (CEO : median worker): 137:1Fuller H B Co
Bristol Myers Squibb Co vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Bristol Myers Squibb Co's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Bristol Myers Squibb Co

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
131:1
FY2025
vs prior FY
+14:1
from FY2024 117:1
CEO $ YoY
+17%
$21.9M latest
Filings shown
5
FY2021–2025
Bristol Myers Squibb Co CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $19.8M - $148,649 133:1 -
2022 $20.0M +1.1% $149,162 134:1 +1:1
2023 $19.7M -1.6% $151,172 130:1 -4:1
2024 $18.7M -4.7% $160,144 117:1 -13:1
2025 $21.9M +17% $167,191 131:1 +14:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 14272, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
131:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$21.9M
Companies in Industry
168
vs. Industry Median
Above
#31 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Bristol Myers Squibb Co: MID · PEAK pay ratio

Bristol Myers Squibb Co's FY2025 ratio 131:1 ranks #31 of 168 Chemicals & Pharmaceuticals filers (82nd percentile). the CEO earned 131× the median employee ($167,191) in FY2025.

Median employee $167,191 (ELITE-MED); MID · PEAK stamps put about 131 median-wage years per CEO year.

CEO Total Pay

$21.9M

FY2025 Summary Compensation, well above median

Pay Ratio

131:1

Near industry median

Bristol Myers Squibb Co in the higher Chemicals & Pharmaceuticals third

Bristol Myers Squibb Co's FY2025 ratio 131:1 ranks #31 of 168 Chemicals & Pharmaceuticals filers (82nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Bristol Myers Squibb Co's $21.9M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #146 and ratio rank #494 split - treat 131:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$21.9M
Median Employee Pay
$167,191
Pay Ratio
131:1
Filing Date
2026-03-25

Company Info

CIK
14272
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
SEC EDGAR DEF 14A for CIK 14272, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read with Bristol Myers Squibb Co

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.

Data sourced from SEC EDGAR DEF 14A for Bristol Myers Squibb Co (CIK 14272), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.